Physician profile
Randy A Mccool
NPI 1093711517
$1,986.80
in general payments reported to CMS, 2019-2025
31 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $317 · 2020: $266 · 2021: $261 · 2022: $509 · 2023: $348 · 2024: $286.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $634.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $634.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $196.93 | 2020-2024 | Aptima, Myosure Tissue Removal Device, Affirm Prone Biopsy System |
| Therapeuticsmd, INC. | $165.07 | 2019-2022 | |
| Abbvie INC. | $162.17 | 2019-2023 | |
| Sumitomo Pharma America, INC. | $142.90 | 2023-2024 | Myfembree |
| Pfizer INC. | $120.34 | 2019-2024 | |
| Coopersurgical, INC. | $111.73 | 2019-2024 | Paragard T 380a, Paragard T 380a |
| Amgen INC. | $102.76 | 2019-2023 | Evenity, Prolia |
| Mayne Pharma Commercial LLC | $89.37 | 2021-2022 | |
| Aspira Women'S Health INC | $86.55 | 2022 | |
| Merck Sharp & Dohme LLC | $86.41 | 2019-2024 | Gardasil 9, Gardasil |
| Myovant Sciences INC. | $78.03 | 2021-2022 | |
| Agile Therapeutics, INC. | $68.65 | 2022-2024 | Twirla |
| Exeltis, USA INC. | $64.87 | 2019-2024 | Slynd |
| Organon LLC | $61.47 | 2021-2024 | |
| Mylan Pharmaceuticals INC. | $59.06 | 2019-2020 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shield Therapeutics INC | $51.99 | 2023-2024 | Accrufer |
| Bayer Healthcare Pharmaceuticals INC. | $50.29 | 2019-2022 | |
| Astellas Pharma US INC | $38.08 | 2023-2024 | Veozah |
| Exact Sciences Corporation | $37.62 | 2023 | Cologuard Collection Kit |
| Boston Scientific Corporation | $25.67 | 2019 | |
| Amag Pharmaceuticals, INC. | $22.99 | 2019 | |
| Scynexis, INC. | $22.89 | 2022 | |
| Becton, Dickinson and Company | $22.82 | 2021 | |
| Novo Nordisk INC | $21.46 | 2022 | |
| Medicem INC. | $20.04 | 2020 | |
| Minerva Surgical, INC | $14.00 | 2023 | |
| Medtronic, INC. | $13.22 | 2023 | Venaseal |
| Dysis Medical, INC. | $13.04 | 2019 | |
| Avion Pharmaceuticals | $12.89 | 2020 | |
| Allergan, INC. | $12.06 | 2019 | |
| Tactile Systems Technology INC | $11.43 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Randy Mccool listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.